BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. financial statements

BridgeBio Pharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 502.08M10-K
Net income−USD 724.93M10-K
Cash and equivalentsUSD 570.12M10-Q
Total debtUSD 2.01B10-K

BridgeBio Pharma, Inc. financials on 6ix · BridgeBio Pharma, Inc. on 6ix